These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15477397)

  • 21. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial.
    James S; Akerblom A; Cannon CP; Emanuelsson H; Husted S; Katus H; Skene A; Steg PG; Storey RF; Harrington R; Becker R; Wallentin L
    Am Heart J; 2009 Apr; 157(4):599-605. PubMed ID: 19332184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of a next-day follow-up electrocardiogram in patients with non-ST elevation acute coronary syndromes.
    Alkaabi S; Baslaib F; Casanova A; Yan AT; Fitchett D; Mendelsohn A; Nikhil JY; Langer A; Goodman SG;
    Am Heart J; 2008 Oct; 156(4):797-803. PubMed ID: 18926163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry.
    Lim MJ; Spencer FA; Gore JM; Dabbous OH; Agnelli G; Kline-Rogers EM; Dibenedetto D; Eagle KA; Mehta RH;
    Eur Heart J; 2005 Jun; 26(11):1063-9. PubMed ID: 15716281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.
    Wiviott SD; Braunwald E; Angiolillo DJ; Meisel S; Dalby AJ; Verheugt FW; Goodman SG; Corbalan R; Purdy DA; Murphy SA; McCabe CH; Antman EM;
    Circulation; 2008 Oct; 118(16):1626-36. PubMed ID: 18757948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndrome.
    Kassem-Moussa H; Mahaffey KW; Graffagnino C; Tasissa G; Sila CA; Simes RJ; White HD; Califf RM; Bhapkar MV; Newby LK;
    Am Heart J; 2004 Sep; 148(3):439-46. PubMed ID: 15389230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of circulating total homocysteine levels on long-term cardiovascular mortality in patients with acute coronary syndromes.
    Foussas SG; Zairis MN; Makrygiannis SS; Manousakis SJ; Patsourakos NG; Adamopoulou EN; Beldekos DJ; Melidonis AI; Handanis SM; Manolis AJ; Hatzisavvas JJ; Argyrakis SK
    Int J Cardiol; 2008 Mar; 124(3):312-8. PubMed ID: 17433477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors and 1-year outcome of major bleeding in patients with non-ST-elevation acute coronary syndromes: insights from the Canadian Acute Coronary Syndrome Registries.
    Segev A; Strauss BH; Tan M; Constance C; Langer A; Goodman SG;
    Am Heart J; 2005 Oct; 150(4):690-4. PubMed ID: 16209967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome.
    Leung S; Gallup D; Mahaffey KW; Cohen M; Antman EM; Goodman SG; Harrington RA; Langer A; Aylward P; Ferguson JJ; Califf RM;
    Am Heart J; 2008 Jul; 156(1):177-84. PubMed ID: 18585514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial.
    Morrow DA; Antman EM; Murphy SA; Qin J; Ruda M; Guneri S; Jacob AJ; Budaj A; Braunwald E;
    Am Heart J; 2007 Dec; 154(6):1078-84, 1084.e1. PubMed ID: 18035078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of admission heart failure in patients with non-ST-elevation acute coronary syndromes (from the Canadian Acute Coronary Syndrome Registries).
    Segev A; Strauss BH; Tan M; Mendelsohn AA; Lai K; Ashton T; Fitchett D; Grima E; Langer A; Goodman SG;
    Am J Cardiol; 2006 Aug; 98(4):470-3. PubMed ID: 16893699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure of aspirin to prevent myocardial infarction and adverse outcome during follow-up - a large series of all-comers.
    Mikkelsson J; Eskola M; Nikus K; Karhunen PJ; Niemela K
    Ann Med; 2008; 40(4):296-302. PubMed ID: 18428022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding.
    Wang TY; Xiao L; Alexander KP; Rao SV; Kosiborod MN; Rumsfeld JS; Spertus JA; Peterson ED
    Circulation; 2008 Nov; 118(21):2139-45. PubMed ID: 18981304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ST-segment deviation on the admission electrocardiogram, treatment strategy, and outcome in non-ST-elevation acute coronary syndromes A substudy of the Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) Trial.
    Windhausen F; Hirsch A; Tijssen JG; Cornel JH; Verheugt FW; Klees MI; de Winter RJ;
    J Electrocardiol; 2007; 40(5):408-15. PubMed ID: 17604045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics and outcome of diabetic patients with acute myocardial infarction. Data from the BLITZ-1 study.
    Casella G; Savonitto S; Chiarella F; Gonzini L; Di Chiara A; Bolognese L; De Servi S; Greco C; Zonzin P; Coccolini S; Maggioni AP; Boccanelli A;
    Ital Heart J; 2005 May; 6(5):374-83. PubMed ID: 15934409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual antiplatelet agent failure: a new syndrome or clinical nonentity?
    Barnes GD; Li J; Kline-Rogers E; Vedre A; Armstrong DF; Froehlich JB; Eagle KA; Gurm HS
    Am Heart J; 2007 Oct; 154(4):732-5. PubMed ID: 17893001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial.
    Zeymer U; Gitt A; Jünger C; Bauer T; Heer T; Koeth O; Mark B; Zahn R; Senges J; Gottwik M
    Thromb Haemost; 2008 Jan; 99(1):155-60. PubMed ID: 18217148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The influencing factors of surviving time of patients with non-ST elevation acute coronary syndromes in China].
    Liang Y; Zhu J; Tan HQ; Li JD; Liu LS
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):873-8. PubMed ID: 16029522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent platelet activation is related to very early cardiovascular events in patients with acute coronary syndromes.
    Małek ŁA; Spiewak M; Filipiak KJ; Grabowski M; Szpotańska M; Rosiak M; Główczyńska R; Imiela T; Huczek Z; Opolski G
    Kardiol Pol; 2007 Jan; 65(1):40-5; discussion 46. PubMed ID: 17295159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis.
    Ferrari E; Benhamou M; Cerboni P; Marcel B
    J Am Coll Cardiol; 2005 Feb; 45(3):456-9. PubMed ID: 15680728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.